- Home
- IKT vs AMRN Comparison
IKT vs AMRN Comparison
Compare IKT & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- AMRN
- Stock Information
- Founded
- IKT 2008
- AMRN 1989
- Country
- IKT United States
- AMRN Ireland
- Employees
- IKT N/A
- AMRN N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- IKT Health Care
- AMRN Health Care
- Exchange
- IKT Nasdaq
- AMRN Nasdaq
- Market Cap
- IKT 167.2M
- AMRN 189.2M
- IPO Year
- IKT 2020
- AMRN 1993
- Fundamental
- Price
- IKT $1.90
- AMRN $9.11
- Analyst Decision
- IKT Buy
- AMRN Sell
- Analyst Count
- IKT 2
- AMRN 2
- Target Price
- IKT $8.00
- AMRN $7.00
- AVG Volume (30 Days)
- IKT 147.0K
- AMRN 103.6K
- Earning Date
- IKT 05-14-2025
- AMRN 04-30-2025
- Dividend Yield
- IKT N/A
- AMRN N/A
- EPS Growth
- IKT N/A
- AMRN N/A
- EPS
- IKT N/A
- AMRN N/A
- Revenue
- IKT N/A
- AMRN $228,614,000.00
- Revenue This Year
- IKT N/A
- AMRN N/A
- Revenue Next Year
- IKT N/A
- AMRN $5.18
- P/E Ratio
- IKT N/A
- AMRN N/A
- Revenue Growth
- IKT N/A
- AMRN N/A
- 52 Week Low
- IKT $1.12
- AMRN $7.00
- 52 Week High
- IKT $4.20
- AMRN $20.60
- Technical
- Relative Strength Index (RSI)
- IKT 42.84
- AMRN 48.45
- Support Level
- IKT $1.58
- AMRN $8.32
- Resistance Level
- IKT $2.22
- AMRN $10.06
- Average True Range (ATR)
- IKT 0.22
- AMRN 0.87
- MACD
- IKT 0.00
- AMRN 0.15
- Stochastic Oscillator
- IKT 45.57
- AMRN 60.40
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.